Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
| Cat.No. | Product Name | Price |
|---|---|---|
| CSC-DC004127 | Panoply™ Human DDO Knockdown Stable Cell Line | Inquiry |
| CSC-SC004127 | Panoply™ Human DDO Over-expressing Stable Cell Line | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| AD04681Z | Human DDO adenoviral particles | Inquiry |
| LV10463L | human DDO (NM_004032) lentivirus particles | Inquiry |
| LV10464L | human DDO (NM_003649) lentivirus particles | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| SHG226475 | shRNA set against Mouse Ddo(NM_027442.5) | Inquiry |
| SHG226357 | shRNA set against Human DDO(NM_004032.2) | Inquiry |
| SHG226385 | shRNA set against Human DDO(NM_003649.2) | Inquiry |
| SHH275701 | shRNA set against Human DDO (NM_003649.2) | Inquiry |
| SHH275705 | shRNA set against Mouse DDO (NM_027442.5) | Inquiry |
| SHH275709 | shRNA set against Rat DDO (NM_001109465.2) | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| CDCR286123 | Human DDO ORF Clone(NM_003649.2) | Inquiry |
| CDCR376047 | Rat Ddo ORF Clone(NM_001109465.2) | Inquiry |
| CDFH004883 | Human DDO cDNA Clone(NM_003649.2) | Inquiry |
| CDFH004884 | Human DDO cDNA Clone(NM_004032.2) | Inquiry |
| CDFR009000 | Rat Ddo cDNA Clone(NM_001109465.2) | Inquiry |
| MiUTR1H-02712 | DDO miRNA 3'UTR clone | Inquiry |
| MiUTR1H-02713 | DDO miRNA 3'UTR clone | Inquiry |
| MiUTR1M-03741 | DDO miRNA 3'UTR clone | Inquiry |
| CDCB188219 | Rabbit DDO ORF clone (XM_008263368.1) | Inquiry |
| CDCR054242 | Human DDO ORF clone (NM_004032.2) | Inquiry |
| CDCS411389 | Human DDO ORF Clone (BC032786) | Inquiry |
Ddo (D-aspartate oxidase) gene, a member of the aspartate oxidase family, has been widely studied for its significant role in various biological processes. In eukaryotes, acidic D-amino acids are primarily being degraded by D-aspartate oxidase (DDO or DASPO, EC:1.4.3.1), but in the mouse heart, D-glutamate is metabolized mainly by D-glutamate cyclase (EC4.2.1.48), a flavonase that catalyzes the oxidative deamination of acidic D-amino acids to form the corresponding α-keto acids and ammonia. The reduced FAD is re-oxidized by molecular oxygen to produce hydrogen peroxide. DDO and DAAO are thought to have originated from the same ancestor due to the high degree of similarity in their amino acid sequences. 70 years ago, researchers first detected DDO in rabbit kidneys and livers, and it is now known to be present in eukaryotic organisms ranging from fungi to humans. it has not yet been detected in prokaryotic organisms or plants. in fungi, DDO is responsible for the toxicity of the D-Asp for cell growth and the elimination of the D-Asp. In fungi, DDO is required for cell growth on D-Asp and eliminates the toxicity of D-Asp. In mammals, DDO plays a key role in D-Asp metabolism and is involved in the regulation of D-Asp levels during physiological processes.
DO typically contains the Wierenga sequence for ADP binding at the N-terminus (GXGXXG, where X is an arbitrary amino acid) and the PTS1 sequence at the C-terminus (S/T/A/G/C/N-R/K/H-L/I/V/M/A/F/Y, PROSITE, PS00342). The human enzyme was shown to localize to the peroxisome, although the PTS1 sequence (SNL) of the human enzyme does not correspond to the consensual sequence. hDDO-1 encompasses the entire coding region and generates proteins that contain 341 amino acid residues, whereas hDDO-2 is an internally truncated form of hDDO-1 (282 amino acid residues). hDDO-1 and the other mammalian DDOs have the hDDO-1 and other mammalian DDOs have the same number of amino acid residues and high amino acid sequence identity (about 75% to 91%).
References: